Vampires have peaked as investment opportunities thanks to Twilight and all the multivarious vampire based TV series. Pitches are going on all over town for new YA series featuring the Last Vampire on Earth beseiged in a mansion by an army of vampire slayers, the only vampire at an exclusive girl's school or some AV HS nerds who go in for vampirism to improve their social position. Saavy Investors are looking at a plateau situations with more creatives piling in, less dividends paid out.
Zombies are approaching a plateau situation, critical market stressors include the Walking Dead TV series, a plethora of graphic novels and a continuing output of new tentpole movies featuring Romero-template zombies. Flesh eating ghouls are still a short term Blue Chip Bet with Saavy Investors running the numbers in their heads furtively darting their eyes at the lifeboats.
Everyone on the street is still talking up Frankenstein's monster on the basis of strong pre-war and post war performance, but Big Frank hasn't been heard from since the Branagh-De Niro merger back in 1994, Saavy Investors are waiting for a Steve Jobs to innovate Frankenstein back to market dominance.
The Wolf Man? The dirty secret here is the old howler is a niche market performer, a penny stock despite strong brand penetration. A long time favorite of Lady's Garden Club investment roundtables who have happy memories of Lon Chaney Jr nonetheless Saavy Investors politely give lycanthropy a pass.
The Mummy: A dependable investment with the same creative blockage as Frankenstein's monster, hamstrung unfairly as a kidvid dependable due to the association with Brendan Fraser. Saavy Investors though are enamored with the Mummy's vast install base derived from the ongoing popularity of Ancient Egypt exhbibitions.
The Field:
Imps, Leprechauns, The Master Works of Edgar Allen Poe, Japanese Product, public domain fairy tales...and of Sarah Michelle Gellar. All worthwhile ground floor opportunities, just steer clear of the Disney Channel.
No comments:
Post a Comment